R Ivy Carroll

Title: R Ivy Carroll: Innovator in Multidrug Resistance Solutions

Introduction

R Ivy Carroll is a notable inventor based in Durham, NC (US). He has made significant contributions to the field of pharmaceuticals, particularly in combating multidrug resistance in cancer treatment. His innovative approach has the potential to enhance the effectiveness of antineoplastic agents.

Latest Patents

Carroll holds a patent for "Aminoanthraquinone derivatives to combat multidrug resistance." This patent describes potentiating agents that inhibit the development of multidrug resistance, reduce drug resistance in drug-resistant tumors, or sensitize tumors to antineoplastic drugs. The agents are aminoanthraquinones, specifically 1,4-bis(N-substituted) amino anthraquinones, along with their pharmaceutically acceptable salts. This invention represents a significant advancement in cancer therapy.

Career Highlights

Throughout his career, Carroll has worked with esteemed institutions such as Duke University and Pharmaceuticals Corporation. His work has focused on developing innovative solutions to complex medical challenges, particularly in oncology.

Collaborations

Carroll has collaborated with notable professionals in his field, including Clifford W Sachs and Robert L Fine. These partnerships have contributed to the advancement of his research and the development of his patented technologies.

Conclusion

R Ivy Carroll's contributions to the field of pharmaceuticals, particularly in addressing multidrug resistance, highlight his role as an influential inventor. His work continues to pave the way for advancements in cancer treatment and patient care.